-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| ISIN | US98985X1000 |
| PE Ratio | None |
|---|---|
| Target Price | 2.3 |
| Beta | nan |
| Market Cap | 254M |
| Dividend Yield | 0.0% |
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ZY using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025